Enhancement and Suppression of Ionisation in Drug Analysis Using Hplc-Ms/Ms in Support of Therapeutic Drug Monitoring : A Review of Current Knowledge of Its Minimisation and Assessment
Ultra-high performance liquid chromatography tandem mass spectrometry for cyclosporine analysis in human whole blood and comparison with an antibody-conjugated magnetic immunoassay
Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid
External Evaluation Of Population Pharmacokinetic Models Of Infliximab In Inflammatory Bowel Disease Patients
Lack of Detection of New Amphetamine-like Drugs using Conventional Urinary Immunoassays
Multi-Center Evaluation of a New Electrochemiluminescence Immunoassay (Eclia) For Everolimus Concentrations in Whole Blood
Therapeutic Drug Monitoring of Asparaginase Activity - Method Comparison of MAATTM and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial
Influence Of Comedication On Levetiracetam Pharmacokinetics
Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients with Hematologic Malignancies
Therapeutic Drug Monitoring of Busulfan for The Management of Pediatric Patients : Cross-Validation of Methods And Long-Term Performance
Proficiency testing for meropenem and piperacillin therapeutic drug monitoring : preliminary results from the Belgian Society on Infectiology and Clinical Microbiology PK-PD working group
A Systematic Review Of Salivary Versus Blood Concentrations Of Anti-Tuberculosis Drugs And Their Potential For Salivary Therapeutic Drug Monitoring
Comparison Of Anti-Xa And Activated Partial Thromboplastin Time Monitoring For Heparin Dosing In Vascular Surgery Patients : A Single-Center Retrospective Study
Acute Intoxications And Fatalities From Illicit Fentanyl And Analogues : An Update
Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate
Influence of renal function on pharmacokinetics of antiepileptic drugs metabolized by CYP3A4 in a patient with renal impairment
Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients
Companion and Complementary Diagnostics–Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in NSCLC